No abstract available
MeSH terms
-
Adult
-
Aged
-
Antineoplastic Agents, Hormonal / adverse effects
-
Antineoplastic Agents, Hormonal / therapeutic use
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Aromatase Inhibitors / adverse effects
-
Aromatase Inhibitors / therapeutic use
-
Breast Neoplasms / drug therapy*
-
Breast Neoplasms / mortality*
-
Breast Neoplasms / pathology
-
Breast Neoplasms / surgery
-
Chemotherapy, Adjuvant
-
Dose-Response Relationship, Drug
-
Drug Administration Schedule
-
Estrogen Antagonists / adverse effects
-
Female
-
Humans
-
Mastectomy / methods
-
Maximum Tolerated Dose
-
Middle Aged
-
Neoplasm Staging
-
Prognosis
-
Randomized Controlled Trials as Topic
-
Survival Analysis
-
Treatment Outcome
Substances
-
Antineoplastic Agents, Hormonal
-
Aromatase Inhibitors
-
Estrogen Antagonists